Genetic screening of fertilised eggs for embryo selection during assisted reproduction makes no...
New Revenue Record for maxon motor
The maxon motor group achieved a new revenue record in 2017. The company has increased its revenues to CHF459m with growth in all markets and expansion of production capacity at all sites.
Researchers develop smart wristband to monitor health condition
Researchers at Rutgers University-New Brunswick have developed a smart wristband that uses a biosensor technology to monitor personal health conditions.
Genetic screening before IVF does not improve pregnancy chances
Genetic screening of fertilised eggs for embryo selection during assisted reproduction makes no difference to live birth rates, according to an international study funded by the European Society of Human Reproduction and Embryology.
Q&A Perchlorate-Free Detergents
Q) We are looking for a laboratory dishwasher detergent that does not contain perchlorates. One of our end users analyses for trace levels of perchlorates, so we cannot have a detergent that has that type of impurities.
Webinar: Template Design for Performance Evaluation According to Regulation 2017/746
NSF has announced it will be hosting a complimentary webinar that will discuss the requirements of Regulation 2017/746 (IVDR) on performance evaluations.
Applications in Medical Device Manufacturing
The use of aqueous cleaning in medical device manufacturing can provide numerous benefits in terms of efficacy, minimal surface contact and reduced potential and easier cleaning validation.
Advantages and Practical Applications of High-Resolution Encoders
An increasing number of high-resolution encoders have been introduced to the market in recent years. With its compact ENX 16 RIO, maxon motor has presented a high-end model. But what applications benefit most from high-encoder resolutions?
New device to monitor foetal movements in high-risk pregnancies
Researchers at Imperial College London have developed a new sensor-based device to monitor foetal movements in high-risk pregnancies.
Neuromodulation: where to invest next?
For an investor, neuromodulation is a double-edged sword. Although it is one of the fastest growing medical device markets in the healthcare industry, it involves a mechanism of action that is not fully understood. As a result, the market hinges on a few experimental results that could halt the industry.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.